Read More Pharma Industry News Boehringer Ingelheim to acquire NBE-Therapeutics for €1.1bn Boehringer Ingelheim has entered into a transformative €1.18 billion agreement to acquire NBE-Therapeutics, a clinical-stage biotech company based… bypharmanewsdailyDecember 11, 2020